142 related articles for article (PubMed ID: 11150395)
1. Cost analysis of transthoracic cardioversion of atrial fibrillation with and without ibutilide pretreatment.
Oral H; Knight BP; Sticherling C; Kim MH; Baker RL; Chough SP; Wasmer K; Pelosi F; Michaud GF; Fendrick AM; Strickberger SA; Morady F
J Cardiovasc Pharmacol Ther; 2000 Oct; 5(4):259-66. PubMed ID: 11150395
[TBL] [Abstract][Full Text] [Related]
2. Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment.
Oral H; Souza JJ; Michaud GF; Knight BP; Goyal R; Strickberger SA; Morady F
N Engl J Med; 1999 Jun; 340(24):1849-54. PubMed ID: 10369847
[TBL] [Abstract][Full Text] [Related]
3. Ibutilide in persistent atrial fibrillation refractory to conventional cardioversion methods.
Naegeli B; Straumann E; Bertel O
Int J Cardiol; 2005 Mar; 99(2):283-7. PubMed ID: 15749188
[TBL] [Abstract][Full Text] [Related]
4. Is pretreatment with ibutilide useful for atrial fibrillation cardioversion when combined with biphasic shock?
Mazzocca G; Corbucci G; Venturini E; Becuzzi L
J Cardiovasc Med (Hagerstown); 2006 Feb; 7(2):124-8. PubMed ID: 16645372
[TBL] [Abstract][Full Text] [Related]
5. Clinical and cost comparison of ibutilide and direct-current cardioversion for atrial fibrillation and flutter.
Murdock DK; Schumock GT; Kaliebe J; Olson K; Guenette AJ
Am J Cardiol; 2000 Feb; 85(4):503-6, A11. PubMed ID: 10728961
[TBL] [Abstract][Full Text] [Related]
6. Facilitating internal cardioversion of chronic atrial fibrillation with ibutilide--predictors of atrial defibrillation-threshold decrease.
Efremidis M; Sideris A; Batra R; Manolatos D; Xidonas S; Kardara D; Ekonomou D; Evagelou D; Filippatos G; Kardaras F
Med Sci Monit; 2004 Jun; 10(6):CR258-63. PubMed ID: 15173670
[TBL] [Abstract][Full Text] [Related]
7. The cost-effectiveness of ibutilide versus electrical cardioversion in the conversion of atrial fibrillation and flutter to normal rhythm.
Zarkin GA; Bala MV; Calingaert B; VanderLugt JT
Am J Manag Care; 1997 Sep; 3(9):1387-94. PubMed ID: 10178487
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and cost analysis of ibutilide.
Dunn AB; White CM; Reddy P; Chow MS; Kluger J
Ann Pharmacother; 2000 Nov; 34(11):1233-7. PubMed ID: 11098333
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of ibutilide in cardioversion of atrial flutter and fibrillation.
Nair M; George LK; Koshy SK
J Am Board Fam Med; 2011; 24(1):86-92. PubMed ID: 21209348
[TBL] [Abstract][Full Text] [Related]
10. An update on electrical cardioversion of atrial fibrillation.
Mittal S; Stein KM; Markowitz SM; Iwai S; Guttigoli A; Lerman BB
Card Electrophysiol Rev; 2003 Sep; 7(3):285-9. PubMed ID: 14739729
[TBL] [Abstract][Full Text] [Related]
11. Ibutilide Effectiveness and Safety in the Cardioversion of Atrial Fibrillation and Flutter in the Community Emergency Department.
Vinson DR; Lugovskaya N; Warton EM; Rome AM; Stevenson MD; Reed ME; Nagam MR; Ballard DW;
Ann Emerg Med; 2018 Jan; 71(1):96-108.e2. PubMed ID: 28969929
[TBL] [Abstract][Full Text] [Related]
12. Cost effectiveness of ibutilide with prophylactic magnesium in the treatment of atrial fibrillation.
Coleman CI; Kalus JS; White CM; Spencer AP; Tsikouris JP; Chung JO; Kenyon KW; Ziska M; Kluger J; Reddy P
Pharmacoeconomics; 2004; 22(13):877-83. PubMed ID: 15329032
[TBL] [Abstract][Full Text] [Related]
13. Single dose of ibutilide for conversion of persistent atrial fibrillation after radiofrequency ablation.
Hou Y; Fang PH; Liu J; Li XF; Hu JQ; Zhang S
Chin Med J (Engl); 2011 Mar; 124(5):710-3. PubMed ID: 21518563
[TBL] [Abstract][Full Text] [Related]
14. Comparison of verapamil and ibutilide for the suppression of immediate recurrences of atrial fibrillation after transthoracic cardioversion.
Sticherling C; Ozaydin M; Tada H; Oral H; Pelosi F; Knight BP; Strickberger SA; Morady F
J Cardiovasc Pharmacol Ther; 2002 Jul; 7(3):155-60. PubMed ID: 12232564
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of ibutilide for chemical cardioversion of atrial fibrillation and atrial flutter in cancer patients.
Bickford CL; Agarwal R; Urbauer DL; Durand JB; Lenihan DJ
Am J Med Sci; 2014 Apr; 347(4):277-81. PubMed ID: 23588261
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy of ibutilide for cardioversion of persistent atrial fibrillation during radiofrequency ablation].
Tian XC; Wang YM; Gao LJ; Lin YB; Li YW; Xia YL; Zhang SL; Yang YZ
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Nov; 39(11):1029-32. PubMed ID: 22336457
[TBL] [Abstract][Full Text] [Related]
17. Termination of recent-onset atrial fibrillation/flutter in the emergency department: a sequential approach with intravenous ibutilide and external electrical cardioversion.
Domanovits H; Schillinger M; Thoennissen J; Nikfardjam M; Janata K; Brunner M; Laggner AN
Resuscitation; 2000 Aug; 45(3):181-7. PubMed ID: 10959017
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of cardioversion and antiarrhythmic therapy in nonvalvular atrial fibrillation.
Catherwood E; Fitzpatrick WD; Greenberg ML; Holzberger PT; Malenka DJ; Gerling BR; Birkmeyer JD
Ann Intern Med; 1999 Apr; 130(8):625-36. PubMed ID: 10215558
[TBL] [Abstract][Full Text] [Related]
19. Cardioversion of persistent atrial fibrillation by a combination of atrial specific and non-specific class III drugs in the goat.
Blaauw Y; Schotten U; van Hunnik A; Neuberger HR; Allessie MA
Cardiovasc Res; 2007 Jul; 75(1):89-98. PubMed ID: 17466958
[TBL] [Abstract][Full Text] [Related]
20. Enhancing electrical cardioversion and preventing immediate reinitiation of hemodynamically deleterious atrial fibrillation with class III drug pretreatment.
Hayashi M; Tanaka K; Kato T; Morita N; Sato N; Yasutake M; Kobayashi Y; Takano T
J Cardiovasc Electrophysiol; 2005 Jul; 16(7):740-7. PubMed ID: 16050832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
